Charles Schwab’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $596K | Buy |
189,315
+19,341
| +11% | +$60.9K | ﹤0.01% | 3079 |
|
2025
Q1 | $534K | Buy |
169,974
+68,310
| +67% | +$214K | ﹤0.01% | 3061 |
|
2024
Q4 | $441K | Sell |
101,664
-19,629
| -16% | -$85.2K | ﹤0.01% | 3181 |
|
2024
Q3 | $324K | Buy |
121,293
+12,503
| +11% | +$33.4K | ﹤0.01% | 3272 |
|
2024
Q2 | $242K | Buy |
108,790
+92,391
| +563% | +$205K | ﹤0.01% | 3416 |
|
2024
Q1 | $87.6K | Hold |
16,399
| – | – | ﹤0.01% | 3316 |
|
2023
Q4 | $24.3K | Hold |
16,399
| – | – | ﹤0.01% | 3469 |
|
2023
Q3 | $22.8K | Hold |
16,399
| – | – | ﹤0.01% | 3501 |
|
2023
Q2 | $24.1K | Hold |
16,399
| – | – | ﹤0.01% | 3536 |
|
2023
Q1 | $27.1K | Hold |
16,399
| – | – | ﹤0.01% | 3465 |
|
2022
Q4 | $23K | Hold |
16,399
| – | – | ﹤0.01% | 3483 |
|
2022
Q3 | $26K | Hold |
16,399
| – | – | ﹤0.01% | 3455 |
|
2022
Q2 | $37K | Sell |
16,399
-86,744
| -84% | -$196K | ﹤0.01% | 3432 |
|
2022
Q1 | $256K | Buy |
103,143
+5,380
| +6% | +$13.4K | ﹤0.01% | 3261 |
|
2021
Q4 | $588K | Hold |
97,763
| – | – | ﹤0.01% | 3094 |
|
2021
Q3 | $652K | Buy |
97,763
+12,146
| +14% | +$81K | ﹤0.01% | 3052 |
|
2021
Q2 | $570K | Buy |
+85,617
| New | +$570K | ﹤0.01% | 3123 |
|
2020
Q4 | – | Sell |
-11,636
| Closed | -$166K | – | 3399 |
|
2020
Q3 | $166K | Buy |
+11,636
| New | +$166K | ﹤0.01% | 3206 |
|
2017
Q2 | – | Sell |
-491
| Closed | -$41K | – | 3108 |
|
2017
Q1 | $41K | Hold |
491
| – | – | ﹤0.01% | 3044 |
|
2016
Q4 | $75K | Hold |
491
| – | – | ﹤0.01% | 3055 |
|
2016
Q3 | $159K | Hold |
491
| – | – | ﹤0.01% | 2957 |
|
2016
Q2 | $161K | Hold |
491
| – | – | ﹤0.01% | 2994 |
|
2016
Q1 | $165K | Hold |
491
| – | – | ﹤0.01% | 2936 |
|
2015
Q4 | $191K | Hold |
491
| – | – | ﹤0.01% | 2969 |
|
2015
Q3 | $202K | Hold |
491
| – | – | ﹤0.01% | 2955 |
|
2015
Q2 | $359K | Buy |
+491
| New | +$359K | ﹤0.01% | 2798 |
|